Too Much Buzz over that Study About Eating Fish and MS?
I’m not a fish eater. I never have been. Unless the seafood is lobster, shrimp, clams, or crab cakes…
Articles by Ed Tobias
MS Can Be a Kids’ Disease, Too (Part 2)
After I wrote about pediatric MS earlier this month, a reader commented: “I think it would behoove your…
MS News that Caught My Eye Last Week: Zinbryta, Fish Oil, MS Associate Certification, Blood-brain Barrier
Biogen and AbbVie Voluntarily Withdraw Marketing Authorizations for MS Therapy Zinbryta You may have heard…
Getting Cash Back for Choosing Medical Services
You know about credit cards that offer you cash back for the items you buy. How about getting…
MS Can Be a Kids’ Disease, Too
The age at which a person is diagnosed with MS is usually between 20 and 50, according to…
MS News that Caught My Eye Last Week: Epstein-Barr Virus, Gilenya, Naltrexone, Medical Marijuana
Epstein-Barr Virus Found in Brain Cells of Many MS Patients, Study Reports This study is yet…
What’s Hot and What’s Not Among MS Therapies?
The newest kids on the MS block, disease-modifying therapies (DMT) such as Genentech’s Ocrevus (ocrelizumab) and Sanofi Genzyme’s Lemtrada…
MS News that Caught My Eye Last Week: Mediterranean Diet, Medical Marijuana, Ocrevus, Myelin Repair
Pilot Study Is Testing Whether Mediterranean Diet Can Help MS Patients There’s been a good deal of…
How Bad Are Proposed Changes to the Americans with Disabilities Act?
My knee was jerking the other day. It wasn’t my MS, it was my knee-jerk reaction to the passage…
Looking for Healthcare Answers on the Internet Can Drive You Nuts
I know, I know. I write about health issues on the internet, so I shouldn’t be discouraging…
MS News that Caught My Eye Last Week: Stem Cell Trial, Medical Marijuana, Myelin Repair, Tysabri Study
Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial This is encouraging news for…
Peeking Behind the Curtain at Medical Insurance Decisions
Several years ago, I tried to get my insurance company to approve a functional electronic stimulator (FES).
Where Are the Handicapped Parking Spots?
It’s nice when a negative experience can be turned into one that’s positive. I think that’s the result for…
MS News that Caught My Eye Last Week: 3rd Round of Lemtrada, Ampyra’s Possibilities, Long-term MD1003, Possible PML Treatment
#ACTRIMS2018 – Third Course of Lemtrada Improves Relapse, Disability in MS Patients, CARE-MS II Trial Shows The normal treatment…
Good News for Tysabri Users Who Are JCV Positive
One of the many disease-modifying therapies (DMTs) that I’ve been on over the many years of my treatment for…
Is It Time to Change Your MS Doctor?
The other day, as I cruised around various MS internet groups, I came across a lament that I’ve seen…
MS News that Caught My Eye Last Week: Testosterone and MS, Ocrevus in the UK, Enhanced MRI Technology, Ublituximab Trial Results
Researchers Identify Testosterone-triggered Molecule That Protects Men From MS This finding is an extension…
Affording Your MS … or Not, You’re Likely Paying Either Way
Have you been in this Catch-22? You had great medical insurance when you were working. But, you’re not working…
The Big Pharma-Government Revolving Door Is Spinning
You may have heard that there’s a new secretary of Health and Human Services (HHS) in the United States.
MS News that Caught My Eye Last Week: Medical Marijuana Gum, Brain Stimulation and Fatigue, Gilenya Study, Invisible Diseases
Holland Approves Clinical Trial Plans for AXIM’s Cannabis-based Gum for MS Pain and Spasticity Because the state…
Cooking Dinner when MS Fatigue Has You Down
The TV was on as background noise the other day, but the words of the commercial cut right through…
Who Are You to Tell Me What MS Therapy I Need?
I’m used to seeing insurance companies here in the United States make decisions about MS therapies, including refusing…
MS News that Caught My Eye Last Week: Ocrevus in the EU, Salt and Cognitive Problems, Searching for Myelin, Tecfidera Tolerance
European Commission Approves Ocrevus to Treat RRMS, PPMS Throughout EU This is a biggie. It’s been nearly…
Heavy-hitting MS Therapies Now Being Used Sooner for Some Patients
I’m sitting in Florida and the start of spring training is only about six weeks from now, so…
A Tough Year to Fight the Flu
I’m fighting a cold. I’m coughing and I’m congested. I’m hoping it’s not the flu. This is not…
MS News that Caught My Eye Last Week: Rituxan, Medical Marijuana for Canadians, Extavia, Atira Trial
Newly Diagnosed MS Patients Stay Longer on Rituxan Than Other Therapies, Study Finds This is a study…
Worrying About the Dye Used in My MRIs
The Food and Drug Administration (FDA) issued a safety alert about gadolinium, the dye that’s injected when…
Diagnosing MS Faster and Better
As we all know, MS is difficult to diagnose. Put another way, it’s easy to misdiagnose. There’s no…
MS News That Caught My Eye Last Week: MRI Dyes, Diagnosis Criteria, Handwriting and MS, Progressive MS Research
FDA Warns of Risks Linked to Gadolinium-based Contrast Agents Used in MRI Scans I had a brain…
My Lemtrada Journey: A New Year’s Update
Happy new year to all. The start of the new year seems like a good time to assess…